Trials / Completed
CompletedNCT01925560
Tolerance and Utilization of Agave Inulin in Healthy Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Illinois at Urbana-Champaign · Academic / Other
- Sex
- All
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to assess the tolerance and utilization of agave inulin. This will be accomplished through analyses of breath and fecal samples to quantify fermentation end-products- hydrogen, carbon dioxide, and methane will be measured in the breath, and short-chain fatty acids, ammonia, phenol, and indole will be measured in feces. Microbial populations will also be measured in fecal samples.
Detailed description
The objective of this study is to assess the tolerance and utilization of agave inulin. This will be accomplished through analyses of breath and fecal samples to quantify fermentation end-products- hydrogen, carbon dioxide, and methane will be measured in the breath, and short-chain fatty acids, ammonia, phenol, and indole will be measured in feces. Microbial populations will also be measured in fecal samples.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Agave Inulin | 3x3 Latin square with 3 periods |
| OTHER | Placebo | control- 0 (zero) grams/day inulin |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-05-01
- Completion
- 2014-05-01
- First posted
- 2013-08-19
- Last updated
- 2014-05-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01925560. Inclusion in this directory is not an endorsement.